Article Details
Retrieved on: 2024-06-15 21:48:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The data revealed that Iomab-B, an antibody drug conjugate targeting CD45 ... The firm's proprietary technology platform utilizes monoclonal antibodies ...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here